Address Latent TB Meds During Admission

May 2024

Meds for latent tuberculosis infection (LTBI) require your close attention...isoniazid, rifampin, rifapentine, etc.

Patients with LTBI don’t feel sick and aren’t contagious...because tuberculosis bacteria are dormant or inactive in their bodies.

If untreated, at least 5% to 10% of these patients will develop tuberculosis disease...previously called active TB.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Compounding Optimize Safety With IV Compounding Robots
Infectious Diseases Be Familiar With Sulbactam/Durlobactam for “CRAB” Pneumonia
Public Health Recognize Human Trafficking Victims Hidden in Plain Sight
Transitions of Care Prevent Med Errors at Transitions of Care
Anticoagulants Prevent Med Errors With Heparin-Induced Thrombocytopenia
Tuberculosis Address Latent TB Meds During Admission
Allergic Reactions Be Aware of a New Omalizumab Indication
NatMed Spotlight Don’t Recommend Berberine as a GLP-1 Agonist Alternative